Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.

Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.

HLA-E binds specifically to MHC class Ia leader peptides in a TAP (transporter associated with antigen processing)-dependent manner. It interacts with CD94/NKG2A receptors on natural killer cells and this inhibits natural killer cell lysis of the cell displaying HLA-E. The crystal structure of HLA-E...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	O'Callaghan, C
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2000

Míreanna comhchosúla

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
de réir: Braud, V, et al.
Foilsithe / Cruthaithe: (1998)

A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement
de réir: Xiaoli Wang, et al.
Foilsithe / Cruthaithe: (2018-12-01)

CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
de réir: Söderström, K, et al.
Foilsithe / Cruthaithe: (1997)

HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
de réir: King, A, et al.
Foilsithe / Cruthaithe: (2000)

Targeting LAG‐3 restores CD8+ T cell effector function through CD94/NKG2‐Qa‐1b signaling
de réir: Zhiqiang Wang, et al.
Foilsithe / Cruthaithe: (2024-12-01)

A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
de réir: Michaëlsson, J, et al.
Foilsithe / Cruthaithe: (2002)

Molecular basis of human natural killer cell recognition of HLA-E (human leucocyte antigen-E) and its relevance to clearance of pathogen-infected and tumour cells.
de réir: O'Callaghan, C
Foilsithe / Cruthaithe: (2000)

Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.
de réir: Braud, V, et al.
Foilsithe / Cruthaithe: (1999)

Regulation of ligands for the activating receptor NKG2D.
de réir: Mistry, A, et al.
Foilsithe / Cruthaithe: (2007)

Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.
de réir: de Matos, C, et al.
Foilsithe / Cruthaithe: (2007)

NKG2D
de réir: O'Callaghan, C
Foilsithe / Cruthaithe: (2009)

Enriched HLA-E and CD94/NKG2A interaction limits antitumor CD8+ tumor-infiltrating T lymphocyte responses
de réir: Abd Hamid, M, et al.
Foilsithe / Cruthaithe: (2019)

Structural and energetic aspects of multispecific immune recognition by NKG2D.
de réir: O'Callaghan, C, et al.
Foilsithe / Cruthaithe: (2003)

HLA class I signal peptide polymorphism determines the level of CD94/NKG2–HLA-E-mediated regulation of effector cell responses
de réir: Lin, Z, et al.
Foilsithe / Cruthaithe: (2023)

Enriched HLA-E and CD94/NKG2a interaction limits anti-tumor CD8+ tumor-infiltrating T lymphocyte responses
de réir: Abd Hamid, M, et al.
Foilsithe / Cruthaithe: (2019)

Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance
de réir: Xiaowei Liu, et al.
Foilsithe / Cruthaithe: (2024-02-01)

A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
de réir: Zachary B Davis, et al.
Foilsithe / Cruthaithe: (2016-02-01)

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
de réir: Nielsen, N, et al.
Foilsithe / Cruthaithe: (2014)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
de réir: Huisman, BD, et al.
Foilsithe / Cruthaithe: (2023)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
de réir: Brooke D. Huisman, et al.
Foilsithe / Cruthaithe: (2023-08-01)

CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
de réir: Tobias Bexte, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Development and function of CD94-deficient natural killer cells.
de réir: Mark T Orr, et al.
Foilsithe / Cruthaithe: (2010-12-01)

CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors
de réir: Chiara Giordano, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Publisher Correction: High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
de réir: Brooke D. Huisman, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.
de réir: Ceara E Walsh, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
de réir: Kerry A. Whalen, et al.
Foilsithe / Cruthaithe: (2023-12-01)

What a Difference an Amino Acid Makes: An All-Atom Simulation Study of Nonameric Peptides in Inhibitory HLA-E/NKG2A/CD94 Immune Complexes
de réir: Eva Prašnikar, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Cellular metabolism controls NKG2D-dependent cellular immunogenicity
de réir: McCarthy, M, et al.
Foilsithe / Cruthaithe: (2013)

Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System
de réir: Aldi Pupuleku, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
de réir: O'Callaghan, C, et al.
Foilsithe / Cruthaithe: (2001)

P1425: ACTIVATED AND EXPANDED NATURAL KILLER CELLS TRANSDUCED WITH AN NKG2D CHIMERIC ANTIGEN RECEPTOR AGAINST ACUTE MYELOID LEUKEMIA
de réir: L. Córdoba, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions
de réir: J. Luis Espinoza, et al.
Foilsithe / Cruthaithe: (2012-09-01)

Investigation of HLA-E intracellular transport and antigen presentation
de réir: He, W
Foilsithe / Cruthaithe: (2023)

The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferent
de réir: Jim Middelburg, et al.
Foilsithe / Cruthaithe: (2023-12-01)

502 Discovery of HX017, a novel NKG2A/CD94 mAb, for potential cancer immunotherapy
de réir: Faming Zhang, et al.
Foilsithe / Cruthaithe: (2023-11-01)

High-Density of FcγRIIIA+ (CD16+) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis
de réir: Marie Denis Musquer, et al.
Foilsithe / Cruthaithe: (2021-06-01)

BLOCKING THE INHIBITORY CD94/NKG2A NK CELL RECEPTOR WITH A NOVEL ANTI-NKG2A MAB ENHANCES THE SUSCEPTIBILITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES (FLS) TO NK CELL-MEDIATED CYTOTOXICITY
de réir: Nielsen, N, et al.
Foilsithe / Cruthaithe: (2012)

Human Leucocyte Antigen-G (HLA-G) and Its Murine Functional Homolog Qa2 in the Trypanosoma cruzi Infection
de réir: Fabrício C. Dias, et al.
Foilsithe / Cruthaithe: (2015-01-01)

The activating receptor NKG2D is an anti-fungal pattern recognition receptor
de réir: Yoav Charpak-Amikam, et al.
Foilsithe / Cruthaithe: (2024-10-01)

NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
de réir: Jagoda Siemaszko, et al.
Foilsithe / Cruthaithe: (2021-06-01)